Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 9/20 | 0.51 |
| ▸ | MAPK11 | Q15759 | 5/20 | 0.51 |
| ▸ | MAPK13 | O15264 | 4/20 | 0.51 |
| ▸ | MAPK12 | P53778 | 4/20 | 0.51 |
| ▸ | MAPK9 | P45984 | 3/20 | 0.51 |
| ▸ | RAF1 | P04049 | 1/20 | 0.51 |
| ▸ | BTK | Q06187 | 2/20 | 0.38 |
| ▸ | PTGES | O14684 | 2/20 | 0.37 |
| ▸ | F2R | P25116 | 1/20 | 0.35 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | CPT1A | P50416 | 1/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4035352 | 0.92 | MAPK14 (0.42) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL8011517 | 0.90 | MAPK14 (0.52) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL4025102 | 0.90 | MAPK14 (0.52) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL4025055 | 0.89 | MAPK14 (0.69) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL4027551 | 0.84 | MAPK14 (0.41) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL4025897 | 0.83 | MAPK14 (0.51) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL8604095 | 0.82 | BTK (0.47) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL8603751 | 0.82 | BTK (0.47) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL4027239 | 0.81 | MAPK14 (0.43) | MAPK14MAPK11MAPK13MAPK12MAPK9 | |
| SCHEMBL4029885 | 0.79 | MAPK14 (0.71) | MAPK14MAPK11MAPK13MAPK12MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0854870-B1 | SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY | MERCK & CO INC (US) | 2009-06-10 | — | — | EP | claimed |